Author | Lightnews

Melanoma Institute Australia @melanomaau.bsky.social · Sep 24

MIA Medical Director, Prof Georgina Long, is leading next group of clinical trials in pre-surgery immunotherapy as life-saving melanoma treatment. Results of one of these latest neoadjuvant immunotherapy trials published in #NatureMedicine > melanoma.org.au/news/new-wav... @gvlongphdmd.bsky.social

1

Melanoma Institute Australia @melanomaau.bsky.social · Sep 23

Today is #WorldCancerResearchDay. When patients, researchers, clinicians & healthcare communities come together, progress in cancer research moves faster. Cancer is a shared, global challenge that demands collaboration to spark the innovations that save lives. #CancerResearchNeedsUsAll #WCRD2025

1

Melanoma Institute Australia @melanomaau.bsky.social · Sep 18

The four-year Govt funded 'Roadmap for a National Targeted Skin Cancer Screening Program' began Mar 2025. MIA is collaborating with a large network of experts & stakeholders to gather evidence & develop consensus recommendations for how targeted screening could work. Read update> bit.ly/4ppjk9X

1

Melanoma Institute Australia @melanomaau.bsky.social · Sep 2

Researchers have reported results from an international clinical trial assessing alternative treatment options for #LentigoMaligna. The trial demonstrated that both radiotherapy and topical imiquimod are effective alternative treatments to surgery. Read more > melanoma.org.au/news/persona...

Melanoma Institute Australia @melanomaau.bsky.social · Sep 1

The Int Neoadjuvant Melanoma Consortium (INMC), which MIA’s @gvlongphdmd.bsky.social is a founder with 3 MD Anderson USA colleagues, awarded 2025 Society for Immunotherapy of Cancer (SITC) Collaboration Award for work pioneering neoadjuvant immunotherapy for melanoma> melanoma.org.au/news/global-...

Melanoma Institute Australia @melanomaau.bsky.social · Aug 15

An inspiring day today at MIA's #ResearchRetreat 2025 where our researchers shared latest updates on their projects with the wider MIA team. The annual event provides opportunity for understanding, collaborating & strategising, as we work towards our goal of zero deaths from melanoma. #Melanoma

Melanoma Institute Australia @melanomaau.bsky.social · Jul 14

An inspiring insight into @gvlongphdmd.bsky.social in #TheAustralian.
“One of the world’s leading melanoma experts, Georgina Long is a warrior. All she thinks about is ‘how to cure the incurable’. Her aim is zero deaths from the cancer … It’s not the only battle she’s staring down.” bit.ly/3IsuidJ

Melanoma Institute Australia @melanomaau.bsky.social · Jun 27

Don’t miss the opportunity to donate this tax time to support our world-leading ‘bench to bedside’ research, and help us ultimately save ALL lives from melanoma.
Please donate by this Monday 30 June> melanoma.org.au/donate/

Melanoma Institute Australia @melanomaau.bsky.social · Jun 25

MIA's new 'Neoadjuvant immunotherapy for melanoma' patient resource leaflet explains important neoadjuvant immunotherapy info: what it is, benefits, multidisciplinary approach, what to expect before, during & after, common side effects & more.
Access free #patientresource > bit.ly/44yaLAY #melanoma

1

Melanoma Institute Australia @melanomaau.bsky.social · Jun 24

Latest #MelanomaInsights podcast: Is sentinel node biopsy still recommended in 2025 with the rise of #neoadjuvant immunotherapy? Search “Melanoma Insights” in podcast app or listen here> bit.ly/4kaGnkV (free, clinicians only, login needed). #SNB

2

Melanoma Institute Australia @melanomaau.bsky.social · Jun 22

Thanks to #NADINA clinical trial, led by MIA with Netherlands colleagues, #neoadjuvant (pre-surgery) use of combination #immunotherapy drugs nivolumab and ipilimumab approved by #PBAC & will be listed on #PBS as treatment for Stage III melanoma. @9news.bsky.social
@gvlongphdmd.bsky.social

1

Melanoma Institute Australia @melanomaau.bsky.social · Jun 4

MIA surgeon A/Prof Alex van Akkooi delivered oral abstract at #ASCO25 on results of COLUMBUS-AD trial run thru @eortc.org - randomised trial of adjuvant encorafenib & binimetinib v placebo in pts with high risk Stage II melanoma with BRAF mutation. Promising results for this post-surgery treatment.

1

Melanoma Institute Australia @melanomaau.bsky.social · Jun 4

At #ASCO25 Prof Georgina Long delivered oral on RELATIVITY-098 trial (combi of nivolumab & relatlimab v nivolumab alone in Stage III & Stage IV pts post surgery). Negative results, so whilst combi IO works for adv melanoma, doesn’t work post-surgery as ‘mop up’ therapy.
@gvlongphdmd.bsky.social

Melanoma Institute Australia @melanomaau.bsky.social · Jun 2

The melanoma & skin cancer poster session at #ASCO25 featured 11 posters involving MIA researchers. A/Prof Ines da Silva led 3 projects, 1 relating to predicting response to neoadjuvant immunotherapy in melanoma, & 2 about immunotherapy for cutaneous SCC. See MIA’s ASCO posters here> bit.ly/3FspPXn

1

Melanoma Institute Australia @melanomaau.bsky.social · Jun 2

MIA clinicians & researchers in Chicago for #ASCO25, sharing latest research results. MIA’s Prof Georgina Long to deliver oral presentation on adjuvant IO trial results. MIA’s A/Profs Alex van Akkooi, Ines daSilva & Alex Menzies also presenting & MIA team sharing posters. @gvlongphdmd.bsky.social

Melanoma Institute Australia @melanomaau.bsky.social · May 24

On #ClinicalTrialsDay we celebrate the patients who participate in clinical trials. We recognise their quiet courage, often in the face of limited treatment options, to choose to participate. They don’t just receive experimental treatment, they willingly contribute to revolutionising melanoma care.

Melanoma Institute Australia @melanomaau.bsky.social · May 24

MIA participated in Australasian Skin Cancer Congress (#ASCC) Gold Coast 16-18 May. Theme #PartnersInPrevention. Three MIA speakers- Dr Amelia Taylor (neoadjuvant & systemic therapies), Prof Anne Cust (Roadmap for National Targeted Skin Cancer Screening Program) & A/Prof Robyn Saw (genetic testing).

Melanoma Institute Australia @melanomaau.bsky.social · May 20

The working party updating the 'Clinical Practice Guidelines for the Diagnosis & Management of Melanoma' is seeking comment from clinicians & community. First 6 chapters are updated & are open for public comment by 30 Jun. Supported by MIA & Cancer Council Aus. See> www.cancer.org.au/clinical-gui...

Melanoma Institute Australia @melanomaau.bsky.social · May 19

Three studies led by researchers at MIA are paving the way for less surgical & drug intervention for early stage melanoma patients.
#JITC #TheLancet #AnnalsOncology #APrifAlexMenzies @gvlongphdmd

Read more> melanoma.org.au/news/minimis...

2

Melanoma Institute Australia @melanomaau.bsky.social · May 15

In latest 'Melanoma Insights' podcast for clinicians we explore the cutting-edge role of #AI in diagnosing #melanoma. Join dermatologists #ProfPGuitera & #ProfVMar & pathologist #DrNMaher as they unpack how AI is transforming clinical practice. Listen in usual podcast app or here> bit.ly/3ESaAqw

Melanoma Institute Australia @melanomaau.bsky.social · May 12

Happy International Nurses Day! MIA is proud to support advancement of nursing roles through our Melanoma Nurses Program. The Fed Govt committed to provide $12.2m to support 30 FTE melanoma nurses by 2026 & so far 27 nurses have been appointed around Aus- inc Linda from VIC & Aries from NT. #IND2025

Melanoma Institute Australia @melanomaau.bsky.social · May 11

Congrats to Yuan Ni for graduating with a PhD at @sydney.edu.au. Yuan was on MIA's #research team while completing his PhD: “The Epidemiology of Multiple Primary Melanomas in Australia”. Now he heads to Adelaide for a postdoctoral position at the #SAHMRI. Best of luck with your future career, Yuan!

2

Melanoma Institute Australia @melanomaau.bsky.social · May 9

MIA has been awarded a NHMRC grant to lead an international clinical trial aiming to safely reduce surgery for high risk Stage III melanoma patients who have had a good response to neoadjuvant immunotherapy.
Read more> bit.ly/3EYXfMZ
@gvlongphdmd.bsky.social #AlexVanAkkooi @sydney.edu.au

MIA awarded prestigious NHMRC grant

MIA has been awarded an NHMRC grant to lead an international clinical trial aiming to safely reduce surgery for high risk Stage III melanoma patients who have had a good response to neoadjuvant immuno...

bit.ly

Melanoma Institute Australia @melanomaau.bsky.social · May 7

Clinicians, visit MIA's booth at the #AustralasianSkinCancerCongress, 16-18 May, The Star, Gold Coast! In person & virtual tix available> bit.ly/43gG8iW
This year's theme is #PartnersInPrevention.
MIA has 3 speakers presenting: Prof Anne Cust, A/Prof Robyn Saw & Dr Amelia Taylor.

Melanoma Institute Australia @melanomaau.bsky.social · May 1

The fear of #melanoma returning is a common experience following a melanoma diagnosis. So, we've put together a 'How to cope with fear of melanoma returning' fact sheet, providing practical strategies & resources to help #MelanomaPatients cope with this fear. Access free fact sheet> bit.ly/4jCECxx